Phlox Therapeutics

Description: Phlox Therapeutics develops RNA-based gene therapies to treat and cure cardiomyopathies, targeting genetic mutations unmet by current care.

Country: Netherlands

Based in: Naarden

Founded: 2022

Funding Stage: Pre-Seed

Tags: ['Pharmaceutical Manufacturing', 'Cardiomyopathies', "RNA's"]

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.